Page 9 - Torrent Pharma

Torrent Pharma: Strong base, robust outlook

Higher R&D spending and improving US pipeline to help keep growth rates healthy

Torrent Pharma Q4 PAT up 175% to Rs 375 cr

Revenues up 30% y-o-y to Rs 1,499 cr; full-year profit doubles to Rs 2,930 cr

Torrent Pharma seeks shareholder nod to raise Rs 10,500 cr

The company plans to use the funds for organic and inorganic growth

Torrent Pharma plans to raise funds via QIP, others

Company in a filing to the BSE said that its board on March 23 will consider 'the proposal for raising of funds'

Torrent Pharma's Dahej plant gets EIR from USFDA

It is the third plant of Torrent to receive USFDA approval out of its five manufacturing units